Skip to main content

Table 1 Proteins identified by mass spectrometry after separation with PEP technology and Hexokinase Activity Analysis

From: Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology

Sample number

Sample location in PEP plate

Tentative protein ID

Sample-1

N19A

Plasminogen (PLG)

Sample-2

N7B, N8B

Hemopexin (HPX)

Sample-3

N22H, N23H, N22I

Complement Component 3 (C3)

Sample-4

N17J, N18J

Fatty Acid Synthase (FASN)

Sample-5

N18K, N19K

Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)

Sample-6

N10M, N11M

Fatty Acid Synthase (FASN)

Sample-7

N15M, N16M

Enolase 1 (ENO1)

Sample-8

N1P, N2P, N3P

Glyceralde-3-phosphate Dehydrogenase

Sample-9

N10P, N11P

Alpha-2-glycoprotein 1 (AZGP1)

Sample-10

C3A

Fatty Acid Synthase (FASN)

Sample-11

C9A, C9B

Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)

Sample-12

C19D, C20D, C21D

Pyruvate Kinase (PKM)

Sample-13

C19E, C20E, C21E

Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)

Sample-14

C14O, C14P

Fatty Acid Synthase (FASN)

Sample-15

C21P

Fatty Acid Synthase (FASN)

  1. *The location of each protein on the 2-D gel was defined by two parameters: the serum group and the location on the 384-plate. 1. The serum group is represented by the first letter, N represents Normal Serum, and C represents Cancer Serum. For example, N19A represents sample from Normal Serum and the PEP plate well 19A